发明名称 BIOMARKERS FOR DIFFERENTIATING MELANOMA FROM BENIGN NEVUS IN THE SKIN
摘要 Disclosed is a method for diagnosing melanoma in a human subject, as well as a method for providing a prognosis to a human subject who is at risk of developing melanoma recurrence, and a method for determining the stage of melanoma in a human subject, comprising the step of determining the level of expression of phosphatase and actin regulator 1 (PHACTR1) gene, or fragments thereof, either alone or in combination with the level of expression of secreted integrin-binding phosphoprotein (SPP1), preferentially expressed antigen in melanoma (PRAME), growth differentiation factor 15 (GDF 15), and chemokine C-X-C motif ligand 10 (CXCL10) genes. Further, the invention relates to a diagnostic kit, comprising at least one substance for detection of the expression of PHACTR1, or fragments thereof, either alone or in combination with the detection of SPP1, PRAME, GDF15, and CXCL10, for the diagnosis or prognosis of melanoma.
申请公布号 US2012071343(A1) 申请公布日期 2012.03.22
申请号 US201113236889 申请日期 2011.09.20
申请人 MA XIAO-JUN;WU XINGYONG;LUO YULING;ADVANCED CELL DIAGNOSTICS, INC 发明人 MA XIAO-JUN;WU XINGYONG;LUO YULING
分类号 C40B30/04;C12Q1/42;C12Q1/68 主分类号 C40B30/04
代理机构 代理人
主权项
地址